Evolution of changes in cognitive function after the initiation of antiretroviral therapy
Open Access
- 14 April 2016
- journal article
- research article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 13 (1) , 1-5
Abstract
Cognitive function is reported to improve after the initiation of combination antiretroviral therapy (cART). Data on the evolution of such changes are limited. We assessed the dynamics of changes in cognitive parameters, in HIV-positive subjects initiating cART. Cognitive function in seven domains was evaluated for HIV-infected patients without clinically significant cognitive impairment prior to the initiation of cART, and 24 and 48 weeks after. Cognitive scores were transformed using standardised z-scores according to the pooled baseline standard deviation. Global, speed, and accuracy composite z-scores were calculated with changes calculated using a paired t test. In 14 subjects, change in global cognitive z-scores from baseline was by 0.08 at week 24 (p = 0.59) and 0.15 at week 48 (p = 0.43). Change in composite speed and accuracy z-scores from baseline at weeks 24/48 were 0.07/0.05 (p = 0.45/0.82) and 0.13/0.23 (p = 0.47/0.45), respectively. In two of the cognitive domains assessing speed (learning and monitoring time), a continued improvement from baseline to weeks 24 and 48 was observed (changes of 0.06–0.08 and 0.10–0.19, respectively), whereas in two domains (detection and identification) an initial improvement at week 24 (changes of −0.10 and 0.04 from baseline, respectively) was followed by a deterioration in score at week 48 (changes of −0.12 and −0.08 from baseline, respectively). None of these changes were statistically significant. A trend for improvement in cognitive function was observed in naïve HIV-positive patients starting cART. The dynamics of this improvement differed both between cognitive domains and the time-points assessed.Keywords
Funding Information
- Boehringer Ingelheim (Actually (UK), not (US). Details in manuscript)
This publication has 17 references indexed in Scilit:
- HIV Associated Neurocognitive Disorders in the Modern Antiviral Treatment Era: Prevalence, Characteristics, Biomarkers, and Effects of TreatmentCurrent HIV/AIDS Reports, 2014
- Dynamics of cognitive change in HIV‐infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyHIV Medicine, 2011
- Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the LiteratureJournal of the International Neuropsychological Society, 2011
- Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort StudyClinical Infectious Diseases, 2010
- Understanding the Neuropsychological Consequences of Deployment Stress: A Public Health FrameworkJournal of the International Neuropsychological Society, 2010
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapyNeurology, 2009
- British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008HIV Medicine, 2008
- The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test batteryArchives of Clinical Neuropsychology, 2006
- Reaction Time Performance in Adults With HIV/AIDSJournal of Clinical and Experimental Neuropsychology, 2002
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infectionNeurology, 1991